Skip to main content
Kristen Spencer, DO, Internal Medicine, New York, NY

KristenReneeSpencerDO

Internal Medicine New York, NY

Hematology/Oncology

Physician

Dr. Spencer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Spencer's full profile

Already have an account?

  • Office

    160 E 34th St
    New York, NY 10016
    Phone+1 212-731-6667
    Fax+1 646-754-9841

Education & Training

  • Rutgers Health/New Jersey Medical School
    Rutgers Health/New Jersey Medical SchoolResidency, Emergency Medicine, 2013 - 2017
  • Rutgers Health/Robert Wood Johnson Medical School
    Rutgers Health/Robert Wood Johnson Medical SchoolFellowship, Hematology and Medical Oncology, 2017
  • Rowan University School of Osteopathic Medicine
    Rowan University School of Osteopathic MedicineClass of 2011

Certifications & Licensure

  • NY State Medical License
    NY State License 2022 - 2025
  • NJ State Medical License
    NJ State License 2012 - 2023
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Amplifying the Patient's Voice in Oncology Early-Phase Clinical Trials: Solutions to Burdens and Barriers
    Amplifying the Patient's Voice in Oncology Early-Phase Clinical Trials: Solutions to Burdens and BarriersJune 1st, 2024
  • ECOG-ACRIN Adds Another Trial to the ComboMATCH Precision Oncology Study Platform
    ECOG-ACRIN Adds Another Trial to the ComboMATCH Precision Oncology Study PlatformMay 8th, 2024
  • Perlmutter Cancer Center Appoints New Clinical Trials Leadership, Expands Access to Early-Stage Trials
    Perlmutter Cancer Center Appoints New Clinical Trials Leadership, Expands Access to Early-Stage TrialsJuly 21st, 2022
  • Join now to see all

Professional Memberships